Mutual of America Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Mutual of America Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-260,925	Closed	-$608K	–	1647
2022 Q1	$608K	Sell	260,925 -11,341	-4%	-$35.4K	0.01%	1090
2021 Q4	$1.27M	Sell	272,266 -2,541	-0.9%	-$15.8K	0.01%	1036
2021 Q3	$2.1M	Sell	274,807 -3,959	-1%	-$33.6K	0.02%	940
2021 Q2	$2.7M	Sell	278,766 -11,997	-4%	-$95.5K	0.03%	853
2021 Q1	$2.4M	Buy	290,763 +61,134	+27%	+$646K	0.03%	888
2020 Q4	$1.57M	Buy	229,629 +35,291	+18%	+$283K	0.02%	996
2020 Q3	$2.17M	Buy	194,338 +83,888	+76%	+$768K	0.03%	786
2020 Q2	$694K	Buy	+110,450	New	+$423K	0.01%	1094
2017 Q1	–	Sell	-151,260	Closed	-$741K	–	1237
2016 Q4	$741K	Sell	151,260 -758	-0.5%	-$4.55K	0.01%	1076
2016 Q3	$1.18M	Hold	152,018	–	–	0.02%	977
2016 Q2	$851K	Hold	152,018	–	–	0.02%	1043
2016 Q1	$818K	Sell	152,018 -1,100	-0.7%	-$6.39K	0.02%	1044
2015 Q4	$1.33M	Buy	153,118 +20,796	+16%	+$175K	0.03%	860
2015 Q3	$1.11M	Hold	132,322	–	–	0.03%	933
2015 Q2	$2.33M	Hold	132,322	–	–	0.05%	632
2015 Q1	$1.53M	Sell	132,322 -3,794	-3%	-$43.9K	0.03%	837
2014 Q4	$1.37M	Buy	136,116 +38,425	+39%	+$195K	0.03%	870
2014 Q3	$442K	Buy	97,691 +65,800	+206%	+$353K	0.01%	1128
2014 Q2	$215K	Buy	+31,891	New	+$240K	0.01%	1153

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mutual of America Capital Management's SRNE Position: Q2 2022 in Review

Mutual of America Capital Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2022, closing a stake of 260,925 shares — an estimated $608K sold.

Mutual of America Capital Management first reported a position in SRNE in Q2 2014 and held it in 19 quarters. The position peaked at $2.7M in Q2 2021. 229 funds tracked by Wall St. Rank hold SRNE as of Q2 2022.

Mutual of America Capital Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
Mutual of America Capital Management sold 260,925 Sorrento Therapeutics, Inc. shares in Q2 2022, an estimated $608K.
Mutual of America Capital Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and held it in 19 quarters.
Mutual of America Capital Management's Sorrento Therapeutics, Inc. position peaked at $2.7M in Q2 2021.
229 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2022.

Based on Mutual of America Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.